1. Xie, B., L. Zhang, J. Gao, T. Wang, M. Liu, X. Feng, X. Xu, S. Ma, H. Cai, T. Guo, W. Huang, X. Tu, S. Wang, H. Yang*, Y. Fang*, F. Li*, and C. Chen*(corresponding author), Decoding the biological properties and tranomic landscapes of human natural killer cells derived from bone marrow and umbilical cord blood. Am J Cancer Res, 2023. 13(5): p. 2087-2103. (SCI, IF: 6.16)
2. Si, W., X. Xu, L. Wan, F. Lv, W. Wei, X. Xu, W. Li, D. Huang, L. Zhang*, and F. Li*(corresponding author), RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1. Front Oncol, 2022. 12: p. 996080. (SCI, IF: 4.7)
3. Si, W., C. Kan, L. Zhang*, and F. Li*(corresponding author), Role of RUNX2 in breast cancer development and drug resistance (Review). Oncol Lett, 2023. 25(5): p. 176. (SCI, IF: 4.7)
4. Zhang, L*., S. Yang, H. Chen, C. Xue, T. Wang, S. Chen, X. Xu, S. Ma, M. Yu, T. Guo, Y. Han, J. Yan, J. Shen*, H. Cai*, and F. Li*(corresponding author), Characterization of the biological and tranomic signatures of natural killer cells derived from cord blood and peripheral blood. Am J Cancer Res, 2023. 13(8): p. 3531-3546. (SCI, IF: 6.16)
5. Lu Zhang, Lei Liu,Xiaodan Xu, Xiaogang He, Gang Wang,Chulin Fan, Qiping Zheng, Feifei Li*(corresponding author). miR-205/Runx2 axis negatively regulates CD44+/CD24- Breast cancer stem cell activity. American Journal of Cancer Research, 2020;10(6):1871-1887 (SCI, IF: 6.16)
6. Ping Zhang, Lei Liu, Lu Zhang, Xiaogan He, Xiaojun Xu, Yaojuan Lu, Feifei Li*(corresponding author).Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development. Am J Transl Res 2020;12(5):2305-2318 (SCI,IF:4.06)
7. Xiaodan Xu, Lu Zhang, Xiaogang He, Ping Zhang , Caihong Sun, Xiaojun Xu, Yaojuan Lu, Feifei Li*(corresponding author). TGF-b plays a vital role in triple-negative breast cancer (TNBC) drugresistance through regulating stemness, EMT and apoptosis. Biochemical and Biophysical Research Communications. 2018,(502) 160-165 (SCI,IF:3.575)
8. Minmin Zhang, Feifei Li*(co-first author), Jing Wang, Wenzhu He, Yun Li1, Hongyan Li,Zhaolian Wei, Yunxia Cao. tRNA-derived fragment tRF-03357 promotes cell proliferation, migration and invasion in high-grade serous ovarian cancer. OncoTargets and Therapy 2019:12 6371–6383 (SCI,IF:4.147)
9. YUXI LUO, GUIQIN SONG ,SHICHU LIANG ,FEIFEI LI*(corresponding author), KANG LIU Research advances in chimeric antigen receptormodified T-cell therapy (Review) EXPERIMENTAL AND THERAPEUTIC MEDICINE 2021, 21: 484-489, (SCI, IF:2.447)
10. FeifeiLi*(corresponding author), Rui Mi, Chuling Fan,Ping Zhang, Yaojuan Lu, Junxia Gu, Qiping Zheng.Runx2-interacting genes identified by yeast two-hybrid screening of libraries generated from hypertrophic chondrocytes. Am J Transl Res 2016;8(11).5465-5474 (SCI,IF: 3.40)
11. J Gu, Y Lu, F Li, L Qiao, Q Wang, N Li, JA Borgia, Y Deng, G Lei,and Q Zheng*. Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation. Cell Death and Disease ,2014,5:16 :e1469. (IF: 5.965)
12. Feifei Li, Yaojuan Lu, Ming Ding, Dobrawa Napierala, Sam Abbassi, YuqingChen, Siying Wang, Brendan Lee, and Qiping Zheng. RunX2 Regulates MurineCOL10A1 Expression Through Direct Interaction With Its Cis-Enhancer. Journal of Bone and Mineral Research,2011 Dec;26(12):2899-910 (SCI,IF: 7.1)
13. Feifei Li, Yinan Jiang, Qiping Zheng, Xiaoming Yang and Siying Wang. TECprotein tyrosine kinase is involved in the Erk signaling pathway induced by HGF. Biochemical and Biophysical Research Communications 2011(404), 1: 79-85.(SCI,IF:2.7)8
14. Li F, Lu Y, Ding M, Wu G, Sinha S, Wang S, Zheng Q. Putative Function ofTAP63 during Endochondral Bone Formation. Gene, 2012:495 95–103 (SCI,IF: 2.61)